Compositions and methods for nucleic acid extraction

US10072259B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10072259-B2
Application numberUS-201615212815-A
CountryUS
Kind codeB2
Filing dateJul 18, 2016
Priority dateMar 15, 2013
Publication dateSep 11, 2018
Grant dateSep 11, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compositions and techniques for the extraction, enrichment and isolation of nucleic acids from yeast in a whole blood sample using amine monomers are disclosed herein.

First claim

Opening claim text (preview).

I claim: 1. A method of isolating an extraction solution comprising nucleic acids from yeast in a whole blood sample, said method comprising: a) providing i) a whole blood sample suspected of comprising yeast and ii) an aqueous extraction solution comprising an amine monomer, a chaotrope, and a detergent, wherein said amine monomer is selected from the group consisting of is 2,2′-(ethylenedioxy)bis(ethylamine) (EDBE), 1,3-diaminopropane and 3-amino-1-propanol and wherein the concentration of amine monomer in said aqueous extraction solution is about 30% to about 50% and wherein the concentration of said detergent is about 8% to about 15%; b) contacting said whole blood sample suspected of comprising yeast with said extraction solution resulting in lysis of the yeast and the isolation of an extraction solution comprising nucleic acids. 2. The method of claim 1 , wherein said amine monomer is a primary amine monomer. 3. The method of claim 2 , wherein said amine monomer is 2,2′-(ethylenedioxy)bis(ethylamine) (EDBE). 4. The method of claim 2 , wherein said amine monomer is 1,3-diaminopropane. 5. The method of claim 2 , wherein said amine monomer is 3-amino-1-propanol. 6. The method of claim 1 , wherein said chaotrope is selected from at least one of the group consisting of urea, and guanidine thiocyanate (GITC). 7. The method of claim 6 , wherein the concentration of the chaotrope in said aqueous extraction solution is about 4 M to about 5 M. 8. The method of claim 1 , wherein said detergent is selected from at least one of the group consisting of a polysorbate, deoxycholate, sodium deoxycholate, sodium dodecyl sulfate (SDS), nonyl phenoxypolyethoxylethanol and polyethylene glycol. 9. The method of claim 1 , further comprising an alcohol wherein said alcohol is selected from at least one of the group consisting of ethanol and butanol. 10. The method of claim 9 , wherein the concentration of said alcohol is about 15% to about 25%. 11. The method of claim 1 , wherein said sample is selected from living cellular source material and fixed cellular source material. 12. The method of claim 11 , wherein said living cellular source material comprises a suspension of single cells. 13. The method of claim 11 , wherein said sample comprises formalin-fixed paraffin embedded (FFPE) material. 14. The method of claim 1 , further comprising wherein said aqueous extraction solution is enzyme-free. 15. The method of claim 1 , further comprising wherein said aqueous extraction solution is protease-free. 16. The method of claim 1 , further comprising wherein said nucleic acids are isolated from an extraction solution comprising nucleic acids with additional steps, the additional steps comprising i) adsorbing said nucleic acids onto silica coated magnetic particles by introducing said particles into said extraction solution containing extracted nucleic acids to create nucleic acid adsorbed silica coated magnetic particles; ii) washing said nucleic acid adsorbed silica coated magnetic particles, iii) eluting said nucleic acids from said silica coated magnetic particles into the elution solution and; iv) isolating said nucleic acids from said elution solution. 17. The method of claim 1 , wherein said method excludes mechanical disruption of the yeast.

Assignees

Inventors

Classifications

  • from natural products · CPC title

  • Purine radicals · CPC title

  • Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

  • Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor · CPC title

  • by using magnetic beads · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10072259B2 cover?
Compositions and techniques for the extraction, enrichment and isolation of nucleic acids from yeast in a whole blood sample using amine monomers are disclosed herein.
Who is the assignee on this patent?
Abbott Molecular Inc
What technology area does this patent fall under?
Primary CPC classification C12N15/1003. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).